Express Pharma - Page 545 of 2195 - Express Pharma

Review meeting held on WHO-ICHI Framework, National Health Intervention Codes for ASU

Lupin’s Ankleshwar facility receives EIR from US FDA

MedTherapy details India manufacturing plans for CAR-T and gene therapies

NIH begins clinical trial evaluating second COVID-19 booster shots in adults

A seat at the table: Shaping the healthcare policy landscape

‘The Lancet’ publishes phase-III data of ZyCoV-D

Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion

Florida reaches $878 million opioid settlements with CVS, Teva and others

Express Pharma April 2022

Fresenius agrees two acquisitions to bolster Kabi drugs unit

NHA invites comments on consultation paper on drug registry

FDA authorises second booster of Pfizer/BioNTech and Moderna COVID shots

Monetisation of healthcare: New avenues for patient revenue